The sad thing about this is that this company really could succeed and bring in a lot of profits for everyone, though it seems as though the ceo may just be screwing us over. That's all it takes to ruin an opportunity like this. I would hold if we could at least maintain around mid 2's, but it seems dilution might kill this over the next month or two before news of the finished animal trials comes. It kills me but I might have to put in my first sell order here in the past 6 months at 22.
News 
Market Data 
Discover 
